NCT03077698 2022-06-07
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
Xenetic Biosciences, Inc.
Phase 2 Terminated
Xenetic Biosciences, Inc.
Emory University
GOG Foundation
Par Pharmaceutical, Inc.
Par Pharmaceutical, Inc.
Mayo Clinic